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Community-acquired pneumonia (CAP) is a common cause of presentation to healthcare facilities. The diagnosis
of CAP is usually made in patients with suggestive symptoms, signs, and radiological features. A number of non-infectious
conditions, including neoplastic lesions, pulmonary oedema, pulmonary embolism, drug-induced pneumonitis,
diffuse alveolar haemorrhage syndromes, cryptogenic organising pneumonia and acute eosinophilic pneumonia,
may present in a similar way and mimic CAP. These other conditions are often only thought of after patients that
are being treated as CAP fail to respond to therapy. The non-infectious mimics of CAP require early diagnosis and
appropriate treatment to decrease patient morbidity and mortality. This article is intended to create an awareness
of the non-infectious mimics of CAP and highlight some of the more frequent conditions as well as those that
require early diagnosis and treatment to prevent a poor outcome.
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Community-acquired pneumonia (CAP) is a frequent
and treatable cause of persons presenting to healthcare
practitioners. CAP is an acute infection of the pulmon-
ary parenchyma in a person who has not had regular
exposure to the healthcare system or a recent hospital
admission [1].
CAP is considered as a diagnosis in patients present-
ing with the CAP syndrome, which comprises of two or
more of the following symptoms or signs: fever, new or
increased cough, sputum production, dyspnoea, pleur-
itic chest pain, confusion, crackles or signs of consoli-
dation on chest auscultation, and a leukocytosis [2]. A
chest radiograph with infiltrates compatible with acute
pulmonary infection usually “clinches” the diagnosis of
CAP in the attending clinician’s mind [3]. Despite ad-
vances in healthcare and antibiotic therapy, CAP re-
mains a leading cause of mortality in South Africa [4].
Unfortunately, the symptoms and signs of the CAP
syndrome are not specific and, even with chest radio-
graph features compatible with acute pulmonaryCorrespondence: ablack@wrhi.ac.za
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with CAP may actually have a non-infectious mimic of
CAP [2, 5]. These figures are likely to be an under-
representation of the incidence of mimics of CAP in
clinical practice, as the published data on CAP usually
only includes patients with a clear diagnosis of CAP. A
further diagnostic challenge is that CAP and the mimics
of CAP may coexist in a patient, such as pneumococcal
pneumonia and tuberculosis, pulmonary oedema with
secondary infection or a pulmonary embolism in a bed
bound patient [6]. These non-infectious mimics of CAP
(Table 1) require specific management and without ap-
propriate treatment often have poor outcomes [7].
Infectious biomarkers such as highly sensitive C-
reactive protein (hCRP) and procalcitonin (PCT), while
suggestive of an infectious aetiology, may be raised in
many of the mimics of CAP and do not have sufficient
sensitivity or specificity to rule in CAP or to rule out the
non- infectious mimics; however, they can complement
the diagnostic process [8]. Investigations to determine a
causative agent and confirm the infectious aetiology of
the CAP syndrome yield low results and are often not
done in all patients with a diagnosis of CAP [9].
While there is a wide differential diagnosis for the
CAP syndrome, the high incidence of CAP and the rela-
tively low incidence of CAP mimics makes it appropriateributed under the terms of the Creative Commons Attribution 4.0 International
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apy for CAP, as early antibiotics improves CAP out-
comes [10]. Unless there is strong suspicion of a CAP
mimic at the time of presentation due to atypical fea-
tures such as multi-system disease or peripheral blood
eosinophilia, the mimics of CAP are usually only
thought of in patients with treatment failure for CAP.
Patients with CAP usually show improvement in tach-
ypnoea, tachycardia, and fever within 72 h of starting
antibiotic therapy. Chest radiograph abnormalities take
up to 12 weeks to resolve but stabilisation and reduction
of the infiltrates occurs earlier [11]. Treatment failure
can be considered in three main groups: (i) progressive
pneumonia, where patients show continued deterior-
ation despite antibiotic treatment; (ii) slowly resolving
pneumonia where there is a delay in clinical improve-
ment beyond 72 h or failure to show chest radiograph
improvement after 2 weeks after initiation of antibiotic
treatment; (iii) non-responding pneumonia where pul-
monary infiltrates persist on the chest radiograph be-
yond 12 weeks [7, 11].
In a patient with treatment failure, consideration needs
to be given to known host factors that may increase the
risk of failure such as advanced age, congestive cardiac
failure, hepatic disease and alcohol abuse. The most
common causes of treatment failure are infection with
an antibiotic resistant or an unusual organism or an in-
fectious complication of CAP such as an empyema [11].
The initial management in these patients would be arepeat chest radiograph to look for complications, an es-
calation of antibiotic therapy while reviewing any initial
microbiological specimens, and sending further micro-
biological specimens looking for resistant or unusual or-
ganisms. In areas with high human immunodeficiency
virus infection and tuberculosis prevalence, early testing
for both conditions is strongly recommended in patients
presenting with the CAP syndrome. A complete re-
evaluation of the patient with a comprehensive history
and examination with a full cardiac examination and
cognisance of the non-infectious mimics of CAP needs
to be conducted. Further investigations directed at ex-
cluding or confirming a mimic of CAP need to be con-
sidered. The urgency of further investigations is
determined by the severity of the patient’s illness. A very
high index of suspicion for an alternative diagnosis to
CAP is needed in those patients who present with severe
pneumonia in the absence of hypotension.
Neoplastic lesions
Neoplastic lesions may mimic CAP in two ways; the
most common is an endobronchial lesion, which may be
a primary lung carcinoma or metastatic cancer (malig-
nant melanoma, adenocarcinoma of the breast or gastro-
intestinal tract, or Kaposi’s sarcoma) [7]. Endobronchial
lesions may cause obstruction leading to the accumula-
tion of secretions and predispose the patient to distal in-
fection with resultant fever. The obstructive lesion may
not be apparent on the chest radiograph but hilar or me-
diastinal adenopathy, if present, should raise the index
of suspicion. Computerised axial tomography (CAT)
scan of the chest may show the obstructive lesion, and
fibre-optic bronchoscopy with biopsy is indicated to es-
tablish a diagnosis, particularly in cases when sputum
cytology is negative.
Certain malignancies may present with a pulmonary
infiltrate and areas of consolidation without obstruction
of a bronchus. The most common neoplasm to present
in this way is the bronchioalveolar carcinoma (BAC),
which is usually a mucinous adenocarcinoma of the lung
[12]. Alveolar carcinoma is increasing in incidence and
compared to other primary lung cancers occurs more
frequently in women and non-smokers. Cough is usual
and profuse bronchorrhoea, if present, should raise the
index of suspicion, fever may be present but is unusual.
The chest radiograph may show consolidation. Positron-
emission tomography does not help differentiate be-
tween BAC and infectious pneumonia [13]. Diagnosis is
made with sputum cytology or histology from specimens
obtained from transbronchial biopsy. The prognosis of
patients presenting with the pneumonic form of BAC is
poor [13].
Both Hodgkin’s and Non-Hodgkin’s lymphoma can
present with primary or secondary pulmonary involvement
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masses, but a pattern suggestive of an infectious aeti-
ology may occur. Loss of weight and/or hilar, medias-
tinal or peripheral adenopathy should prompt further
investigation. Fibre-optic bronchoscopy and transbron-
chial biopsy may be diagnostic but usually a surgical bi-
opsy is required to provide an adequate amount of
tissue to confirm the diagnosis.
Pulmonary oedema
Pulmonary oedema frequently presents as a CAP syn-
drome [2]. In patients with areas of altered pulmonary
perfusion due to bullae, chronic obstructive pulmonary
disease or valvular disease, pulmonary oedema may ap-
pear as a localised infiltrate on chest radiograph. An en-
larged cardiac silhouette should increase the suspicion of
cardiac disease. Primary cardiac disease with pulmonary
oedema may predispose a patient to infectious pneumo-
nia. Pneumonia may aggravate existing cardiac pathology
such as cardiomyopathy, valvular disease or ischaemic
heart disease, and induce or worsen congestive cardiac
failure. The examination of a patient with respiratory
symptoms should always include a thorough cardiac
evaluation. In patients with CAP that deteriorate clinic-
ally despite antibiotic treatment, a new cardiac event
such as an acute myocardial infarction or arrhythmia
should be considered [14].
Pulmonary embolism
Pulmonary embolism (PE) may present with the clinical
and radiological features of the CAP syndrome. Early
diagnosis and treatment of PE decreases mortality and
the possibility of PE should be considered in patients
presenting with the CAP syndrome. Biomarkers of in-
fection such as hCRP and PCT, or of thrombosis such
as highly sensitive D-dimers, may be raised in both PE
and CAP and cannot be relied upon to differentiate be-
tween the two conditions; however, together with the
clinical impression these biomarkers may assist in the
decision to proceed with CT pulmonary angiography
(CTPA) [15].
Patients should be risk stratified using a scoring sys-
tem such as Wells’ criteria [16]. Patients with a low
probability of PE with low D-dimer levels do not require
CTPA [16]. Patients with a low probability of PE and
high D-dimer levels (which may be due to infection) re-
quire independent clinical judgment with regards to fur-
ther investigation for PE. Patients with a Wells’ score
suggesting that a PE is likely, despite the possibility of
CAP being an alternative diagnosis, do not require
measurement of D-dimers and require further investiga-
tion for PE. In patients able to tolerate intravenous con-
trast media, CTPA is the investigation of choice. Where
CTPA is contraindicated or not available, a ventilationperfusion (VQ) scan is an alternative; however, chest
radiograph abnormalities may make interpretation diffi-
cult. Proximal vein lower-limb compressive ultrasound
may diagnose a deep vein thrombosis in 36–45 % of pa-
tients with a PE [17]. Diagnosis of a deep vein throm-
bosis allows for full anticoagulation without confirming
a PE with further imaging. However, the majority of pa-
tients with a proven PE will have a negative proximal
vein lower-limb compressive ultrasound examination
and will require further imaging.
Drug-induced pneumonitis
A number of drugs, particularly cytotoxic agents, can
cause pulmonary disease. Illicit drugs associated with
pulmonary disease include heroin (smoked or injected)
and crack cocaine. The use of illicit drugs should be in-
cluded in a drug history. A comprehensive list of drugs
that may cause pulmonary disease can be found at
www.pneumotox.com. Fever, non-productive cough and
dyspnoea are the usual presentation of drug-induced
pneumonitis and occur within weeks or months of initi-
ating therapy/use. Chest radiograph abnormalities may
be absent early on but infiltrates usually develop and
may localise to mimic pneumonia. A detailed drug his-
tory should be obtained from all patients at presentation.
Some drugs such as methotrexate may predispose a pa-
tient to infection and are commonly used in conditions
that may also be associated with pulmonary disease.
High-resolution CAT scan of the chest and fibre-optic
bronchoscopy are not helpful in the diagnosis of drug-
induced pneumonitis, but may exclude the possibility of
an infectious or other non-infectious aetiology as an al-
ternative diagnosis.
Diffuse alveolar haemorrhage syndromes
The diffuse alveolar haemorrhage syndromes are charac-
terised by bleeding into the alveolar spaces and may re-
sult from a number of causes.
Haemoptysis is the usual predominant symptom but
may be absent. General examination may reveal features
of a vasculitic or rheumatological disorder. The chest
radiograph often shows diffuse bilateral opacities, but a
localised infiltrate may mimic pneumonia. Diagnosis is
made with fibre-optic bronchoscopy and sequential
bronchioalveolar lavage. Management is supportive and
includes adequate oxygenation and correction of any co-
agulation abnormalities while trying to identify and treat
the underlying cause [18].
Cryptogenic organising pneumonia
Cryptogenic organising pneumonia (COP) is the idio-
pathic form of organising pneumonia and is classified
under the idiopathic interstitial lung diseases. Patients
are usually in their fifties or sixties and present with
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ation. The chest radiograph features of COP are typically
bilateral with areas of patchy or diffuse consolidation or
ground glass infiltrates. More focal infiltrates may re-
semble pneumonia. Management includes excluding
known causes of COP such as drugs and the rheumatoid
diseases. Diagnosis requires open lung biopsy. Treat-
ment with glucocorticoids usually results in rapid im-
provement [19].
Acute eosinophilic pneumonia
Acute eosinophilic pneumonia usually presents with an
acute history of non-productive cough, dyspnoea, and
fever. Diffuse parenchymal opacities, rather than local-
ised consolidation, are typically seen on chest radio-
graph. Initial full blood count with a differential shows a
neutrophilic leucocytosis but patients with severe pro-
gressive disease may develop an eosinophilia. Diagnosis
is made by fibre-optic bronchoscopy with bronchioal-
veolar lavage demonstrating a significant eosinophilia.
Without treatment, patients develop progressive respira-
tory failure. Treatment with glucocorticoids results in
rapid improvement [20].
Conclusion
As CAP is common, the majority of patients presenting
with the CAP syndrome will have CAP and require the
early administration of appropriate antibiotics as per re-
gional guidelines. While any individual mimic of CAP
may be uncommon, as a group they contribute to a sig-
nificant proportion of patients admitted to hospital for
the CAP syndrome. Initial evaluation of patients present-
ing with the CAP syndrome should include a detailed
drug history and enquiry about risk factors for thrombo-
embolic disease. Examination should include a search
for extrapulmonary and in particular cardiac disease that
may indicate a higher possibility of a non-infectious
mimic of CAP being responsible for the pulmonary
presentation.
Awareness and consideration of mimics of CAP, par-
ticularly in patients with treatment failure or clinical
deterioration, should expedite further investigations.
High-resolution chest CAT scan with mediastinal win-
dows may assist in classifying the aetiology as infectious
or non-infectious [21]. Early fibre-optic bronchoscopy
with bronchioalveolar lavage and transbronchial biopsy
should form part of the work up where a non-
infectious mimic of CAP is suspected. Early correct
diagnosis allows for appropriate therapy and decreased
patient morbidity and mortality.
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